Litcius/Paper detail

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

Rolando Pajon, Nicole A. Doria-Rose, Xiaoying Shen, Stephen D. Schmidt, Sijy O’Dell, Charlene McDanal, Wenhong Feng, Jin Tong, Amanda Eaton, Maha Maglinao, Haili Tang, Kelly E. Manning, Venkata-Viswanadh Edara, Lilin Lai, Madison Ellis, Kathryn M. Moore, Katharine Floyd, Stephanie L. Foster, Christine M. Posavad, Robert L. Atmar, Kirsten E. Lyke, Tongqing Zhou, Lingshu Wang, Yi Zhang, Martin R. Gaudinski, Walker P. Black, Ingelise Gordon, Mercy Guech, Julie E. Ledgerwood, John N. Misasi, Alicia Widge, Nancy J. Sullivan, Paul C. Roberts, John H. Beigel, Bette Korber, Lindsey R. Baden, Hana El Sahly, Spyros Chalkias, Honghong Zhou, Jing Feng, Bethany Girard, Rituparna Das, Anne Aunins, Darin K. Edwards, Mehul S. Suthar, John R. Mascola, David C. Montefiori

2022New England Journal of Medicine391 citationsDOIOpen Access PDF

Topics & Concepts

NeutralizationMedicineVirologyVaccinationVaccination scheduleAntibodyImmunologyBooster (rocketry)DiseaseViral diseaseSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchSARS-CoV-2 detection and testing
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | Litcius